Behind the Scenes of Viking Therapeutics's Latest Options Trends
Portfolio Pulse from Benzinga Insights
Viking Therapeutics (NASDAQ:VKTX) has seen a mix of bullish and bearish options trading, with a recent trend towards bearish sentiment. Despite this, the stock price is up 5.7% at $89.9. Analysts have varied target prices, with an average of $81.2. The company specializes in biopharmaceutical development for metabolic and endocrine disorders.
February 28, 2024 | 2:46 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Viking Therapeutics has seen significant options trading activity, with a bearish trend emerging. The stock price has increased, and analysts have provided varied target prices.
The mixed sentiment in options trading, combined with the recent stock price increase and varied analyst target prices, suggests potential short-term volatility for VKTX. The bearish trend in options trading could indicate investor caution, while the stock's current performance and analyst optimism may counterbalance this sentiment.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100